Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling.

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Professor Ioanna Andreadou

National & Kapodistrian University of Athens, Athens (Greece)

11 More presentations in this session

Presentation thumbnail

Endothelial adenosine-to-inosine RNA editing is indispensable for vascular integrity

Doctor S. Tual-Chalot (Newcastle-Upon-Tyne, GB)

Presentation thumbnail

Intravenous administration of atorvastatin early after cardiac ischemia attenuates adverse left ventricular remodeling, ameliorates cardiac function and limits the deleterious effects of reinfarction

Doctor G. Vilahur (Barcelona, ES)

Presentation thumbnail

Impact of 719 trp>arg polymorphism of kif 6 gene on contrast induced nephropathy and modulation of statin therapy effectiveness

Professor G. De Luca (Messina, IT)

Presentation thumbnail

Carvedilol and its analogue VK-II-86 attenuate stretch-induced manifestations of mechanoelectric feedback.

Miss I. Del Canto Serrano (Valencia, ES)

Abstract Slides

Presentation thumbnail

Uremic toxin induced endothelial dysfunction can be restored by inhibition of the aryl hydrocarbon receptor: implications for cardiovascular disease treatment in chronic kidney disease patients

Doctor A. Kompa (Melbourne, AU)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Session

When time is the issue

Congress Session

Genetics in heart failure

Congress Session

When external causes are the villain?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources